Furthermore, miR-96-mediated downregulation of RAD51 in cancer cell lines increases their sensitivity to chemotherapy agents and leads to cell death35, a result similar to our observations in pulmonary microvascular endothelial cells upon inhibition of bone morphogenetic protein signaling. The gene discussed is RAD51; the disease is cancer.